Cure Rtd Foundation
Public records show a registered, tax-exempt organization in good standing.
What it says it does
To encourage, guide, and fund additional research to improve understanding, diagnosis, and treatment of Riboflavin Transporter Deficiency ("RTD").
- Income
- $559,449
- Spending
- $255,108
- Spent on programs
- 92%
- Reserves
- 76.9 months of spending
- Largest source of income
- donations and private grants, 95%
- Employees
- 1
- Volunteers
- 10
- Highest pay
- $15,000, vp / treasurer
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 100 out of 100. Higher than 81% of charities in its peer group (diseases, $250k to $1m).
Reserves
35 of 35Spendable reserves would cover 76.9 months of spending.
Debt
20 of 20It owes 0% of what it owns.
Living within its means
15 of 15Income exceeded spending by 54% of income.
Income trend
15 of 15Income rose 44% on the year before.
Spending floor
15 of 1591% of spending went to programs and raising each dollar of donations cost 1 cents.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Good: 86 out of 100. Higher than 67% of charities in its peer group (diseases, $250k to $1m).
Independent board
25 of 254 of 5 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
0 of 5Reports no independent review process for its chief executive's pay.
Independent check of accounts
6 of 15Its accounts were not audited or reviewed by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $233,404 spent. Cure RTD Foundation is proud to have funded the five following research projects in advancement of the understanding and treatment of RTD:(a) $107,000 to Fondazione Bambino Gesu Ente Filantropico, a children's research hospital in Rome, Italy. The research project is titled "Unveiling the Underpinning of Mitochondrial Bioenergetics in RTD Motoneurons and Evaluation of Nerve Growth Factor Treatment as Therapeutic Treatment.(b) $52,000 to Children's Medical Research Institute in Australia. This is our second payment on a 2-year grant to begin understanding the eye defects of RTD patients by developing iPSC-derived Retinal Organoids: a 3D model to test the efficacy of the AAV Gene Therapy.(c) $50,000 to University of California, Irvine for a research project titled: "Post-translational modification (PTM) of hRFVT2 in human neuronal cells." The overall goal is to understand the molecular mechanisms regulating RF body homeostasis to design effective therapies for conditions like RTD. The working hypothesis is that hRFVT2 PTMs may be dysregulated in RTD pathologies, and the specific aim is to investigate the role and consequences of hRFVT2 post-translational modifications in the human fibroblast/neuronal system. The expected results will provide information on the neuronal RF transport process under normal conditions and how it is dysregulated in RTD, ultimately assisting in designing effective therapeutic strategies.(d) $14,350 to The Jackson Laboratory to fund a study titled "Pilot Biomarker Evaluation for Riboflavin Transport Deficiency (RTD)" with a purpose to validate histopathological and metabolomic/lipidomic as markers for RTD in B6.(e) $9,450 to UT Southwestern Medical Center for research on a SCL52A2 gene therapy project.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since April 2018.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.